Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 Expression

被引:138
作者
Zhang, Miaomiao
Liu, Qiaofei
Mi, Siping
Liang, Xue
Zhang, Zhiqian
Su, Xiaomin
Liu, Jinyi
Chen, Yingying
Wang, Mengmeng
Zhang, Yuan
Guo, Fenghua
Zhang, Zhujun
Yang, Rongcun [1 ]
机构
[1] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China
基金
中国国家自然科学基金;
关键词
ANTITUMOR IMMUNE-RESPONSE; SIGNALING PATHWAY; CANCER-PATIENTS; T-CELLS; INHIBITION; DIFFERENTIATION; MECHANISM; INDUCTION; THERAPY; ANTIGEN;
D O I
10.4049/jimmunol.1002989
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) were one of the major components of the immune suppressive network. STAT3 has an important role in regulating the suppressive potential of MDSCs. In this study, we found that the expression of STAT3 could be modulated by both miR-17-5p and miR-20a. The transfection of miR-17-5p or miR-20a remarkably reduces the expression of reactive oxygen species and the production of H2O2, which are regulated by STAT3. MDSCs transfected with miR-17-5p or miR-20a are less able to suppress Ag-specific CD4 and CD8 T cells. Importantly, both miR-17-5p and miR-20a alleviate the suppressive function of MDSCs in vivo. The expression of miR-17-5p and miR-20a in tumor-associated MDSCs was found to be lower than in Gr1(+)CD11b(+) cells isolated from the spleens of disease-free mice. Tumor-associated factor downregulates the expression of both miR-17-5p and miR-20a. The modulation of miR-17-5p and miR-20a expression may be important for the process by which patients with a tumor can overcome the immune tolerance mediated by MDSCs. Our results suggest that miR-17-5p and miR-20a could potentially be used for immunotherapy against diseases, especially cancer, by blocking STAT3 expression. The Journal of Immunology, 2011, 186: 4716-4724.
引用
收藏
页码:4716 / 4724
页数:9
相关论文
共 41 条
[11]   Targeting microRNAs in cancer: rationale, strategies and challenges [J].
Garzon, Ramiro ;
Marcucci, Guido ;
Croce, Carlo M. .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (10) :775-789
[12]   Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity [J].
Kortylewski, M ;
Kujawski, M ;
Wang, TH ;
Wei, S ;
Zhang, SM ;
Pilon-Thomas, S ;
Niu, GL ;
Kay, H ;
Mulé, J ;
Kerr, WG ;
Jove, R ;
Pardoll, D ;
Yu, H .
NATURE MEDICINE, 2005, 11 (12) :1314-1321
[13]   Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species [J].
Kusmartsev, S ;
Gabrilovich, DI .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (02) :186-196
[14]   Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species [J].
Kusmartsev, S ;
Nefedova, Y ;
Yoder, D ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :989-999
[15]   Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation [J].
Lai, EC .
NATURE GENETICS, 2002, 30 (04) :363-364
[16]   miR-223 suppresses differentiation of tumor-induced CD11b+Gr1+myeloid-derived suppressor cells from bone marrow cells [J].
Liu, Qiaofei ;
Zhang, Miaomiao ;
Jiang, Xingran ;
Zhang, Zhiqian ;
Dai, Lingyun ;
Min, Siping ;
Wu, Xilong ;
He, Qingsheng ;
Liu, Jingyi ;
Zhang, Yuan ;
Zhang, Zhujun ;
Yang, Rongcun .
INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (11) :2662-2673
[17]   Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor [J].
Marigo, Ilaria ;
Bosio, Erika ;
Solito, Samantha ;
Mesa, Circe ;
Fernandez, Audry ;
Dolcetti, Luigi ;
Ugel, Stefano ;
Sonda, Nada ;
Bicciato, Silvio ;
Falisi, Erika ;
Calabrese, Fiorella ;
Basso, Giuseppe ;
Zanovello, Paola ;
Cozzi, Emanuele ;
Mandruzzato, Susanna ;
Bronte, Vincenzo .
IMMUNITY, 2010, 32 (06) :790-802
[18]   Modulation of the antitumor immune response by complement [J].
Markiewski, Maciej M. ;
DeAngelis, Robert A. ;
Benencia, Fabian ;
Ricklin-Lichtsteiner, Salome K. ;
Koutoulaki, Anna ;
Gerard, Craig ;
Coukos, George ;
Lambris, John D. .
NATURE IMMUNOLOGY, 2008, 9 (11) :1225-1235
[19]   All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients [J].
Mirza, Noweeda ;
Fishman, Mayer ;
Fricke, Ingo ;
Dunn, Mary ;
Neuger, Anthony M. ;
Frost, Timothy J. ;
Lush, Richard M. ;
Antonia, Scott ;
Gabrilovich, Dmitry I. .
CANCER RESEARCH, 2006, 66 (18) :9299-9307
[20]   Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JS']JSI-124 in a mouse melanoma tumor model [J].
Molavi, Ommoleila ;
Ma, Zengshuan ;
Hamdy, Samar ;
Lai, Raymond ;
Lavasanifar, Afsaneh ;
Samuel, John .
IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (06) :506-514